JP2013516485A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013516485A5 JP2013516485A5 JP2012548156A JP2012548156A JP2013516485A5 JP 2013516485 A5 JP2013516485 A5 JP 2013516485A5 JP 2012548156 A JP2012548156 A JP 2012548156A JP 2012548156 A JP2012548156 A JP 2012548156A JP 2013516485 A5 JP2013516485 A5 JP 2013516485A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- viscosity
- generating agent
- kit
- moxifloxacin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 40
- 239000003795 chemical substances by application Substances 0.000 claims description 35
- 210000003454 tympanic membrane Anatomy 0.000 claims description 15
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 claims description 11
- 229960003702 moxifloxacin Drugs 0.000 claims description 11
- 229920002125 Sokalan® Polymers 0.000 claims description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims description 8
- 210000000959 ear middle Anatomy 0.000 claims description 8
- 239000003961 penetration enhancing agent Substances 0.000 claims description 8
- 239000004584 polyacrylic acid Substances 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 241000124008 Mammalia Species 0.000 claims description 6
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical group CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 4
- 206010050337 Cerumen impaction Diseases 0.000 claims description 4
- 229920002148 Gellan gum Polymers 0.000 claims description 4
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical group C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 4
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 4
- 239000002318 adhesion promoter Substances 0.000 claims description 4
- 230000003444 anaesthetic effect Effects 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 239000000227 bioadhesive Substances 0.000 claims description 4
- 210000002939 cerumen Anatomy 0.000 claims description 4
- 230000009969 flowable effect Effects 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- 239000003230 hygroscopic agent Substances 0.000 claims description 4
- 239000004816 latex Substances 0.000 claims description 4
- 229920000126 latex Polymers 0.000 claims description 4
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical group CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 claims description 4
- 229920001983 poloxamer Polymers 0.000 claims description 4
- 229960000502 poloxamer Drugs 0.000 claims description 4
- 229920001987 poloxamine Polymers 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 229940047670 sodium acrylate Drugs 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 229940005550 sodium alginate Drugs 0.000 claims description 4
- 229920001187 thermosetting polymer Polymers 0.000 claims description 4
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 claims description 3
- -1 anesthetic Substances 0.000 claims description 3
- 229920002301 cellulose acetate Polymers 0.000 claims description 3
- 241000283984 Rodentia Species 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 235000011054 acetic acid Nutrition 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims 1
- 238000000034 method Methods 0.000 description 15
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29301910P | 2010-01-07 | 2010-01-07 | |
| US61/293,019 | 2010-01-07 | ||
| PCT/US2011/020531 WO2011085209A2 (en) | 2010-01-07 | 2011-01-07 | Methods and compositions for applying moxifloxacin to the ear |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016020395A Division JP6267246B2 (ja) | 2010-01-07 | 2016-02-05 | 耳にモキシフロキサシンを適用するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013516485A JP2013516485A (ja) | 2013-05-13 |
| JP2013516485A5 true JP2013516485A5 (enExample) | 2014-02-27 |
Family
ID=44306169
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012548156A Pending JP2013516485A (ja) | 2010-01-07 | 2011-01-07 | 耳にモキシフロキサシンを適用するための方法および組成物 |
| JP2016020395A Expired - Fee Related JP6267246B2 (ja) | 2010-01-07 | 2016-02-05 | 耳にモキシフロキサシンを適用するための方法および組成物 |
| JP2017245040A Pending JP2018076352A (ja) | 2010-01-07 | 2017-12-21 | 耳にモキシフロキサシンを適用するための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016020395A Expired - Fee Related JP6267246B2 (ja) | 2010-01-07 | 2016-02-05 | 耳にモキシフロキサシンを適用するための方法および組成物 |
| JP2017245040A Pending JP2018076352A (ja) | 2010-01-07 | 2017-12-21 | 耳にモキシフロキサシンを適用するための方法および組成物 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20120289541A1 (enExample) |
| EP (2) | EP2521547B1 (enExample) |
| JP (3) | JP2013516485A (enExample) |
| KR (2) | KR20180027611A (enExample) |
| CN (2) | CN102791270A (enExample) |
| AU (1) | AU2011204275B2 (enExample) |
| BR (1) | BR112012016809A2 (enExample) |
| CA (1) | CA2786525A1 (enExample) |
| CL (1) | CL2012001835A1 (enExample) |
| CY (1) | CY1119493T1 (enExample) |
| DK (1) | DK2521547T3 (enExample) |
| ES (1) | ES2644826T3 (enExample) |
| HR (1) | HRP20171592T1 (enExample) |
| HU (1) | HUE035586T2 (enExample) |
| LT (1) | LT2521547T (enExample) |
| MX (1) | MX337419B (enExample) |
| NO (1) | NO2521547T3 (enExample) |
| PH (1) | PH12012501371A1 (enExample) |
| PL (1) | PL2521547T3 (enExample) |
| PT (1) | PT2521547T (enExample) |
| RU (2) | RU2016101214A (enExample) |
| SI (1) | SI2521547T1 (enExample) |
| WO (1) | WO2011085209A2 (enExample) |
| ZA (1) | ZA201205965B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| EP3995160A1 (en) * | 2012-06-28 | 2022-05-11 | The Administrators of the Tulane Educational Fund | Selectively polymerizable compositions |
| CN103869033B (zh) * | 2012-12-14 | 2016-10-05 | 南京长澳医药科技有限公司 | 一种液相色谱法分离测定盐酸莫西沙星及其杂质的方法 |
| JP6255134B1 (ja) * | 2016-11-02 | 2017-12-27 | ヴェローチェ・バイオファーマ・エルエルシー | 耳炎の治療のための組成物および方法 |
| US20210177751A1 (en) * | 2017-12-08 | 2021-06-17 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
| CN108593696B (zh) * | 2018-04-26 | 2020-11-03 | 南京明捷生物医药检测有限公司 | 一种利用定量核磁测定多肽中三氟乙酸残留的方法 |
| CN117045593B (zh) * | 2023-09-19 | 2024-05-28 | 上海市第六人民医院 | 一种用于慢性中耳炎治疗的抗菌温敏水凝胶及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6201072B1 (en) | 1997-10-03 | 2001-03-13 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| AR020661A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
| JP3450805B2 (ja) * | 2000-08-08 | 2003-09-29 | わかもと製薬株式会社 | 水性医薬組成物 |
| US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| JP2008523060A (ja) * | 2004-12-10 | 2008-07-03 | アルコン，インコーポレイティド | 耳感染の処置のための組成物 |
| WO2009142719A2 (en) * | 2008-05-19 | 2009-11-26 | Massachusetts Institute Of Technology | Tympanic membrane permeating ear drops and uses thereof |
-
2011
- 2011-01-07 NO NO11732210A patent/NO2521547T3/no unknown
- 2011-01-07 BR BR112012016809A patent/BR112012016809A2/pt not_active Application Discontinuation
- 2011-01-07 PL PL11732210T patent/PL2521547T3/pl unknown
- 2011-01-07 HU HUE11732210A patent/HUE035586T2/en unknown
- 2011-01-07 CA CA2786525A patent/CA2786525A1/en not_active Abandoned
- 2011-01-07 US US13/520,519 patent/US20120289541A1/en not_active Abandoned
- 2011-01-07 WO PCT/US2011/020531 patent/WO2011085209A2/en not_active Ceased
- 2011-01-07 PH PH1/2012/501371A patent/PH12012501371A1/en unknown
- 2011-01-07 DK DK11732210.7T patent/DK2521547T3/da active
- 2011-01-07 EP EP11732210.7A patent/EP2521547B1/en not_active Not-in-force
- 2011-01-07 HR HRP20171592TT patent/HRP20171592T1/hr unknown
- 2011-01-07 CN CN2011800127647A patent/CN102791270A/zh active Pending
- 2011-01-07 CN CN201610909298.7A patent/CN106309356A/zh not_active Withdrawn
- 2011-01-07 AU AU2011204275A patent/AU2011204275B2/en not_active Ceased
- 2011-01-07 LT LTEP11732210.7T patent/LT2521547T/lt unknown
- 2011-01-07 RU RU2016101214A patent/RU2016101214A/ru not_active Application Discontinuation
- 2011-01-07 MX MX2012007928A patent/MX337419B/es active IP Right Grant
- 2011-01-07 SI SI201131326T patent/SI2521547T1/en unknown
- 2011-01-07 JP JP2012548156A patent/JP2013516485A/ja active Pending
- 2011-01-07 PT PT117322107T patent/PT2521547T/pt unknown
- 2011-01-07 ES ES11732210.7T patent/ES2644826T3/es active Active
- 2011-01-07 RU RU2012133568/15A patent/RU2576029C2/ru not_active IP Right Cessation
- 2011-01-07 KR KR1020187005804A patent/KR20180027611A/ko not_active Ceased
- 2011-01-07 EP EP17186323.6A patent/EP3305280A1/en not_active Withdrawn
- 2011-01-07 KR KR1020127020775A patent/KR101835895B1/ko not_active Expired - Fee Related
-
2012
- 2012-07-06 CL CL2012001835A patent/CL2012001835A1/es unknown
- 2012-08-07 ZA ZA2012/05965A patent/ZA201205965B/en unknown
-
2016
- 2016-02-05 JP JP2016020395A patent/JP6267246B2/ja not_active Expired - Fee Related
-
2017
- 2017-10-18 CY CY20171101086T patent/CY1119493T1/el unknown
- 2017-12-21 JP JP2017245040A patent/JP2018076352A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013516485A5 (enExample) | ||
| JP2021192835A5 (enExample) | ||
| WO2014170755A3 (en) | Sustained-release formulations of colchicine and methods of using same | |
| RU2016101214A (ru) | Способы и композиции для нанесения моксифлоксацина в ухо | |
| HRP20171249T1 (hr) | Postupak, cijev i uređaj za pripremanje pripravka za zarastanje rana | |
| JP2016525572A5 (enExample) | ||
| JP2010525073A5 (enExample) | ||
| JP2011529854A5 (enExample) | ||
| TWI670057B (zh) | 治療乾眼用滴眼劑 | |
| MA34768B1 (fr) | Comprimé orodispersible | |
| CL2011002755A1 (es) | Composicion farmaceutica topica que comprende particulas de fosfato de calcio nanoporosas, esfericas, donde al menos 90% o mas de las particulas tienen un diametro promedio de 2 micrometros o menos y estan enlazadas a un agente farmacologicamente activo. | |
| AR045956A1 (es) | Multiparticulas de pantoprazol y formulacion que las contiene | |
| JP2016500088A5 (enExample) | ||
| CA3010829A1 (en) | Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof | |
| JP2016504367A5 (enExample) | ||
| JP2013510169A5 (enExample) | ||
| JP2014208655A5 (enExample) | ||
| JP2019509345A5 (enExample) | ||
| JP2017516770A5 (enExample) | ||
| CN114845700A (zh) | Otf的可溶性背衬层 | |
| JP2018525419A5 (enExample) | ||
| WO2014204854A8 (en) | Compositions and methods for the preparation of kidney protective agents comprising amifostine and amino acids | |
| RU2005126492A (ru) | Способ местного лечения заболеваний слизистой оболочки полости рта, носа и тканей пародонта при воспалении | |
| JP2024542227A (ja) | 粘膜パッチおよびその使用方法 | |
| JP2015007144A5 (enExample) |